Key Takeaways
- Bank of America maintained its Underperform stance on Salesforce (CRM) with a $160 price target, suggesting approximately 8% potential decline from current trading levels.
- The firm highlighted three major challenges: sluggish customer acquisition, constrained expansion opportunities with existing accounts, and questionable AI revenue generation prospects.
- Shares opened Monday at $173.77, hovering close to the 52-week low of $163.52, reflecting a 25% decline over the previous six-month period.
- Contrary to BofA’s bearish perspective, analyst consensus leans toward Moderate Buy with a mean price target of $274.56.
- The cloud software giant delivered robust Q4 results with earnings of $3.81 per share and $11.20 billion in revenue, while announcing a substantial $25 billion stock repurchase authorization.
Bank of America reaffirmed its Underperform position on Salesforce (CRM) this week, establishing a $160 price objective — calculated using 9x CY27 EV/FCF — which represents approximately 7.9% downside risk from Monday’s opening price of $173.77.
Shares began the week trading dangerously close to their 52-week floor of $163.52, having surrendered approximately 25% of their value during the past half-year. The equity currently trades significantly beneath its 50-day moving average of $184.17.
BofA’s analysis emphasized three fundamental concerns: tepid new account growth, restricted cross-selling and upselling capacity among current clientele, and what analysts characterized as an unconvincing AI monetization strategy.
The financial institution perceives Salesforce as evolving from a rapid-expansion technology leader into a stable, mature enterprise focused on cash flow generation. Their projections anticipate approximately 10% annual growth moving forward — representing a significant deceleration from previous performance levels.
However, the company’s underlying financial health remains solid. Salesforce delivered fourth-quarter earnings of $3.81 per share, substantially exceeding analyst projections of $3.05 by $0.76. Quarterly revenue reached $11.20 billion, marginally surpassing the $11.18 billion consensus estimate and representing 12.1% year-over-year expansion.
Broader Analyst Sentiment
Bank of America’s pessimistic outlook represents a minority position. Among 39 analysts tracking the equity, 25 maintain Buy recommendations, 11 hold neutral positions, and just two — including BofA — advocate selling. One analyst assigns a Strong Buy rating. The consensus price objective stands at $274.56.
Truist Securities preserved its Buy rating with a $280 target following the company’s TDX developer conference presentation. Barclays sustained its Overweight recommendation with a $252 price objective. Jefferies also maintains a Buy rating, though the firm reduced its target from $375 to $250.
Salesforce has implemented strategic measures to bolster shareholder value. This March, the board authorized a $25 billion share repurchase initiative, permitting the company to acquire up to 14.1% of outstanding equity — a strategic decision frequently interpreted as management’s conviction that shares are trading below intrinsic value.
Executive Purchases and Institutional Movement
Two board members acquired shares during March. Laura Alber purchased 2,571 shares at an average price of $194.58, while David Blair Kirk acquired 2,570 shares at $194.62. Both transactions represented substantial additions to their respective holdings.
Institutional investors control 80.43% of outstanding shares, with numerous funds expanding positions throughout Q4. Brighton Jones increased its allocation by 13.7%, and Revolve Wealth Partners boosted its stake by 12.6%.
The enterprise software leader recently reorganized its revenue disclosure framework into two primary segments — Agentforce Apps and Data 360 — mirroring transformations in its product portfolio. The organization also strengthened its collaboration with Google Cloud to implement AI agents throughout Slack and Google Workspace environments.
For fiscal year 2027, Salesforce projects EPS ranging from $13.11 to $13.19, with first-quarter EPS guidance between $3.11 and $3.13. Current analyst expectations anticipate full-year EPS of $9.71.
The stock carries a P/E ratio of 22.25 and a beta coefficient of 1.14, maintaining a gross profit margin of 77.68% alongside a conservative debt-to-equity ratio of 0.18.





